June 24, 2020 / 7:38 PM / 8 days ago

BRIEF-FDA Says Approves Pembrolizumab For Cutaneous Squamous Cell Carcinoma

June 24 (Reuters) - FDA:

* FDA SAYS APPROVES PEMBROLIZUMAB FOR CUTANEOUS SQUAMOUS CELL CARCINOMA

* FDA SAYS APPROVES MERCK & CO., INC.'S PEMBROLIZUMAB DRUG KEYTRUDA Source text: [bit.ly/2NnOuO2] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below